• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植患者的肝切除术:单中心西方经验

Liver resection in transplanted patients: a single-center Western experience.

作者信息

Sommacale D, Dondero F, Sauvanet A, Francoz C, Durand F, Farges O, Kianmanesh R, Belghiti J

机构信息

Department of Hepatopancreatobiliary and Liver Transplantation, Beaujon University-Hospital, APHP, Paris Diderot University (Paris 7), France.

出版信息

Transplant Proc. 2013 Sep;45(7):2726-8. doi: 10.1016/j.transproceed.2013.07.032.

DOI:10.1016/j.transproceed.2013.07.032
PMID:24034033
Abstract

BACKGROUND

Liver resection (LR) in liver transplant (OLT) recipients, an extremely rare situation, who performed on 8 recipients.

METHODS

This retrospective analysis of prospectively collected data concerned 8 (0.66%) 1198 LR cases among OLT performed from 1997 to 2011. We analyzed demographic data, surgical indications, and postoperative courses.

RESULTS

The indications were resectable recurrent hepatocellular carcinomas (HCC, n = 3), persistent fistula from a posterior sectorial duct (n = 1), recurrent cholangitis due to anastomotic stricture on the posterior sectorial duct (n = l), hydatid cyst (n = l), left arterial hepatic thrombosis with secondary ischemic cholangitis (n = 1), and a large symptomatic biliary cyst (n = 1). The mean interval time to liver resection was 23.7 months (range, 5-47). LR included right hepatectomy (n = 1), right posterior hepatectomy (n = 1), left lobectomy (n = 4), pericystectomy (n = 1), or biliary fenestration (n = 1). Which there was no postoperative mortality, the global morbidity rate was 62% (5/8). The mean follow-up after LR was 92 months (range, 11-156). No patients required retransplantation. None of the 3 patients who underwent LR for HCC showed a recurrence.

CONCLUSIONS

LR in OLT recipients is safe, but associated with a high morbidity rate. This procedure can avoid retransplantation in highly selected patients, presenting a possible option particularly for transplanted patients with a resectable, recurrent HCC.

摘要

背景

肝移植(OLT)受者进行肝切除(LR)极为罕见,本研究中有8例受者接受了该手术。

方法

本研究对1997年至2011年期间进行的1198例OLT手术中的8例(0.66%)LR病例进行了回顾性分析。我们分析了人口统计学数据、手术指征和术后病程。

结果

手术指征包括可切除的复发性肝细胞癌(HCC,n = 3)、肝后段胆管持续瘘(n = 1)、肝后段胆管吻合口狭窄导致的复发性胆管炎(n = 1)、包虫囊肿(n = 1)、左肝动脉血栓形成伴继发性缺血性胆管炎(n = 1)和巨大有症状的胆管囊肿(n = 1)。肝切除的平均间隔时间为23.7个月(范围5 - 47个月)。LR包括右肝切除术(n = 1)、右后肝切除术(n = 1)、左叶切除术(n = 4)、囊肿切除术(n = 1)或胆管开窗术(n = 1)。术后无死亡病例,总体发病率为62%(5/8)。LR后的平均随访时间为92个月(范围11 - 156个月)。无患者需要再次移植。3例因HCC接受LR的患者均未出现复发。

结论

OLT受者进行LR是安全的,但发病率较高。该手术可避免在经过严格筛选的患者中进行再次移植,尤其对于患有可切除复发性HCC的移植患者是一种可能的选择。

相似文献

1
Liver resection in transplanted patients: a single-center Western experience.移植患者的肝切除术:单中心西方经验
Transplant Proc. 2013 Sep;45(7):2726-8. doi: 10.1016/j.transproceed.2013.07.032.
2
Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.米兰标准以外的肝细胞癌的外科治疗。肝切除、挽救性移植和原位肝移植的结果。
Ann Surg Oncol. 2008 May;15(5):1383-91. doi: 10.1245/s10434-008-9851-z. Epub 2008 Mar 5.
3
A single-center experience of retransplantation for liver transplant recipients with a failing graft.对移植肝失功的肝移植受者进行再次移植的单中心经验。
Transplant Proc. 2008 Jun;40(5):1485-7. doi: 10.1016/j.transproceed.2008.01.076.
4
Liver resection in liver transplant recipients.肝移植受者的肝切除术
Hepatobiliary Pancreat Dis Int. 2008 Dec;7(6):590-4.
5
Partial hepatic resection for ischemic graft damage after liver transplantation: a graft-saving option?
Surgery. 1994 May;115(5):540-5.
6
Risk factors in liver retransplantation: a single-center experience.肝脏再次移植的风险因素:单中心经验
Transplant Proc. 2011 May;43(4):1110-3. doi: 10.1016/j.transproceed.2011.01.141.
7
Right hepatic lobectomy as a liver graft-saving procedure.
Liver Transpl. 2001 Mar;7(3):269-73. doi: 10.1053/jlts.2001.21318.
8
Highly symptomatic adult polycystic liver disease: options and results of surgical management.高度症状性成人多囊肝病:手术治疗的选择与结果
ANZ J Surg. 2004 Aug;74(8):653-7. doi: 10.1111/j.1445-1433.2004.03112.x.
9
Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience.肝移植作为肝内胆管癌的主要治疗指征:单中心经验
Transplant Proc. 2008 Nov;40(9):3194-5. doi: 10.1016/j.transproceed.2008.08.053.
10
Liver transplantation for hepatocellular carcinoma recurrence after liver resection: why deny this chance of cure?肝切除术后肝癌复发行肝移植:为何拒绝这一治愈机会?
J Clin Gastroenterol. 2013 Apr;47(4):352-8. doi: 10.1097/MCG.0b013e31826e6caf.

引用本文的文献

1
Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma.移植后肝细胞癌复发的治疗策略。
World J Gastroenterol. 2022 Sep 14;28(34):4929-4942. doi: 10.3748/wjg.v28.i34.4929.
2
Impact of Tumour Biology on Outcomes of Radical Therapy for Hepatocellular Carcinoma Oligo-Recurrence after Liver Transplantation.肿瘤生物学对肝移植后肝细胞癌寡复发根治性治疗结局的影响
J Clin Med. 2022 Jul 28;11(15):4389. doi: 10.3390/jcm11154389.
3
The management of post-transplantation recurrence of hepatocellular carcinoma.
移植后肝细胞癌复发的管理。
Clin Mol Hepatol. 2022 Jan;28(1):1-16. doi: 10.3350/cmh.2021.0217. Epub 2021 Oct 5.
4
Outcomes of Liver Resections after Liver Transplantation at a High-Volume Hepatobiliary Center.大型肝胆中心肝移植术后肝切除的结果
J Clin Med. 2020 Nov 17;9(11):3685. doi: 10.3390/jcm9113685.
5
Dynamic tumor-tracking stereotactic body radiation therapy for a solitary tumor in a transplanted organ: two case reports.动态肿瘤追踪立体定向体部放射治疗移植器官中的孤立肿瘤:两例病例报告
Int Cancer Conf J. 2020 Jun 29;9(4):221-226. doi: 10.1007/s13691-020-00429-z. eCollection 2020 Oct.
6
Initial experience with stereotactic body radiotherapy for intrahepatic hepatocellular carcinoma recurrence after liver transplantation.肝移植后肝内肝细胞癌复发的立体定向体部放射治疗的初步经验。
World J Clin Cases. 2020 Jul 6;8(13):2758-2768. doi: 10.12998/wjcc.v8.i13.2758.
7
Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm.多学科方法治疗肝移植后肝细胞癌复发:一种管理算法的建议。
World J Gastroenterol. 2018 Dec 7;24(45):5081-5094. doi: 10.3748/wjg.v24.i45.5081.
8
Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.肝移植术后复发性肝细胞癌的管理:一项系统综述。
World J Gastroenterol. 2015 Oct 21;21(39):11185-98. doi: 10.3748/wjg.v21.i39.11185.
9
Management of recurrent hepatocellular carcinoma after liver transplant.肝移植后复发性肝细胞癌的管理
World J Hepatol. 2015 May 18;7(8):1142-8. doi: 10.4254/wjh.v7.i8.1142.